Estatísticas para RT 1537 2019 - Ocrelizumabe, esclerose múltipla - NATJUS TJMG
Total de visitas
| views | |
|---|---|
| RT 1537 2019 - Ocrelizumabe, esclerose múltipla - NATJUS TJMG | 1 |
Total visitas por mês
| views | |
|---|---|
| December 2024 | 0 |
| January 2025 | 0 |
| February 2025 | 0 |
| March 2025 | 0 |
| April 2025 | 0 |
| May 2025 | 0 |
| June 2025 | 0 |
Visitas Arquivos
| views | |
|---|---|
| RT 1537.pdf | 10 |